Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

5.01
Delayed Data
As of 3:59pm ET
 -0.32 / -6.00%
Today’s Change
3.55
Today|||52-Week Range
23.39
-51.73%
Year-to-Date
No recent news for Osiris Therapeutics Inc.

Today’s Trading

Previous close5.33
Today’s open5.31
Day’s range5.00 - 5.45
Volume184,413
Average volume (3 months)239,791
Market cap$183.6M
Dividend yield--
Data as of 3:59pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)+78.54%
Earnings growth (this year)+260.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+146.29%
P/E ratio102.4
Price/Sales9.15
Price/Book2.18

Competitors

 Today’s
change
Today’s
% change
CBMGCellular Biomedicine...-0.83-5.35%
AKTXAkari Therapeutics P...+1.06+6.61%
ASTAsterias Biotherapeu...-0.19-4.12%
--Wang On Group Ltd-0.00-11.11%
Data as of 4:00pm ET, 05/04/2016

Financials

Next reporting dateMay 6, 2016
EPS forecast (this quarter)$0.01
Annual revenue (last year)$59.9M
Annual profit (last year)-$1.8M
Net profit margin-0.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Bobby Dwayne Montgomery
Chief Operating Officer
Frank D. Czworka
Corporate headquarters
Columbia, Maryland

Forecasts

Partner Offers

Search for Jobs